These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
46. [Neuromelanin in neurons of substantia nigra lacking tyrosine hydroxylase]. Grigor'ev IP; Sukhorukova EG; Kolos EA; Korzhevskiĭ DE Morfologiia; 2012; 141(2):65-7. PubMed ID: 22913142 [TBL] [Abstract][Full Text] [Related]
47. Absorption, distribution and excretion of 14C-chloroquine after single oral administration in albino and pigmented rats: binding characteristics of chloroquine-related radioactivity to melanin in-vivo. Ono C; Yamada M; Tanaka M J Pharm Pharmacol; 2003 Dec; 55(12):1647-54. PubMed ID: 14738591 [TBL] [Abstract][Full Text] [Related]
48. Neuromelanin in the substantia nigra of adult horses. Cozzi B; Pellegrini M; Droghi A Anat Anz; 1988; 166(1-5):53-61. PubMed ID: 3189848 [TBL] [Abstract][Full Text] [Related]
50. [Morphometric assessment of lesions in the dopaminergic nigrostriatal system in Parkinson disease]. Bertrand E; Lechowicz W; Szpak GM; Dymecki J Neurol Neurochir Pol; 1996; 30(5):751-62. PubMed ID: 9148173 [TBL] [Abstract][Full Text] [Related]
51. [Independent benzodiazepine and beta-carboline binding sites in the brain of aggressive and anxious-defensive mice]. Sukhotina IA; Rozhanets VV; Poshivalov VP Biull Eksp Biol Med; 1987 Jun; 103(6):678-81. PubMed ID: 3036270 [TBL] [Abstract][Full Text] [Related]
52. Thallium-201: autoradiography in pigmented mice and melanin-binding in vitro. Tjälve H; Nilsson M; Larsson B Acta Pharmacol Toxicol (Copenh); 1982 Aug; 51(2):147-53. PubMed ID: 7113721 [TBL] [Abstract][Full Text] [Related]
53. Bioactivity of selected materials for coffee substitute. Zawirska-Wojtasiak R; Piechowska P; Wojtowicz E; Przygoński K; Mildner-Szkudlarz S PLoS One; 2018; 13(11):e0206762. PubMed ID: 30439984 [TBL] [Abstract][Full Text] [Related]
54. Melanin affinity: a possible explanation of isoxsuprine retention in the horse. Törneke K; Larsson CI; Appelgren LE Equine Vet J; 2000 Mar; 32(2):114-8. PubMed ID: 10743966 [TBL] [Abstract][Full Text] [Related]
56. The endogeneous formation of highly chlorinated tetrahydro-beta-carbolines as a possible causative mechanism in idiopathic Parkinson's disease. Kochen W; Kohlmüller D; De Biasi P; Ramsay R Adv Exp Med Biol; 2003; 527():253-63. PubMed ID: 15206739 [TBL] [Abstract][Full Text] [Related]
57. Mono-N-methylation of 1,2,3,4-tetrahydro-beta-carbolines in brain cytosol: absence of indole methylation. Matsubara K; Collins MA; Neafsey EJ J Neurochem; 1992 Aug; 59(2):505-10. PubMed ID: 1629723 [TBL] [Abstract][Full Text] [Related]
58. Formation of 1-methyl-beta-carbolines in rats from their possible carboxylic acid precursor. Susilo R; Rommelspacher H Naunyn Schmiedebergs Arch Pharmacol; 1988 May; 337(5):566-71. PubMed ID: 3412494 [TBL] [Abstract][Full Text] [Related]
59. Autoradiography in mice of tritiated 2-(2-furyl)benzimidazole and melanin-binding in vitro. Frank A; Larsson B; Fabiansson S Toxicol Lett; 1983 Jul; 17(3-4):267-73. PubMed ID: 6623521 [TBL] [Abstract][Full Text] [Related]
60. Indole-N-methylation of beta-carbolines: the brain's bioactivation route to toxins in Parkinson's disease? Collins MA; Neafsey EJ; Matsubara K; Cobuzzi R; Albores R; Fields J; Rollema H Ann N Y Acad Sci; 1992 May; 648():263-5. PubMed ID: 1637053 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]